264 related articles for article (PubMed ID: 33094805)
1. eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA.
Wu Y; Xie J; Jin X; Lenchine RV; Wang X; Fang DM; Nassar ZD; Butler LM; Li J; Proud CG
Biochem J; 2020 Nov; 477(22):4367-4381. PubMed ID: 33094805
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis.
Xie J; Shen K; Lenchine RV; Gethings LA; Trim PJ; Snel MF; Zhou Y; Kenney JW; Kamei M; Kochetkova M; Wang X; Proud CG
Int J Cancer; 2018 May; 142(9):1865-1877. PubMed ID: 29235102
[TBL] [Abstract][Full Text] [Related]
3. Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.
Xie J; Van Damme P; Fang D; Proud CG
J Biol Chem; 2019 May; 294(18):7169-7176. PubMed ID: 30890561
[TBL] [Abstract][Full Text] [Related]
4. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
[TBL] [Abstract][Full Text] [Related]
5. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
Bianco C; Thompson L; Mohr I
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Elongation Phase of Protein Synthesis Enhances Translation Accuracy and Modulates Lifespan.
Xie J; de Souza Alves V; von der Haar T; O'Keefe L; Lenchine RV; Jensen KB; Liu R; Coldwell MJ; Wang X; Proud CG
Curr Biol; 2019 Mar; 29(5):737-749.e5. PubMed ID: 30773367
[TBL] [Abstract][Full Text] [Related]
7. Elongation factor eEF2 kinase and autophagy jointly promote survival of cancer cells.
Lenchine RV; Rao SR; Wang X; Fang DM; Proud CG
Biochem J; 2021 Apr; 478(8):1547-1569. PubMed ID: 33779695
[TBL] [Abstract][Full Text] [Related]
8. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.
Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D
Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845
[TBL] [Abstract][Full Text] [Related]
9. Regulation and roles of elongation factor 2 kinase.
Proud CG
Biochem Soc Trans; 2015 Jun; 43(3):328-32. PubMed ID: 26009171
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
Fu LL; Xie T; Zhang SY; Liu B
Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
Beretta S; Gritti L; Verpelli C; Sala C
Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
[TBL] [Abstract][Full Text] [Related]
12. Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.
Jan A; Jansonius B; Delaidelli A; Bhanshali F; An YA; Ferreira N; Smits LM; Negri GL; Schwamborn JC; Jensen PH; Mackenzie IR; Taubert S; Sorensen PH
Acta Neuropathol Commun; 2018 Jul; 6(1):54. PubMed ID: 29961428
[TBL] [Abstract][Full Text] [Related]
13. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
[TBL] [Abstract][Full Text] [Related]
14. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.
Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y
Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751
[TBL] [Abstract][Full Text] [Related]
15. Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy.
Moore CE; Wang X; Xie J; Pickford J; Barron J; Regufe da Mota S; Versele M; Proud CG
Cell Signal; 2016 Apr; 28(4):284-93. PubMed ID: 26795954
[TBL] [Abstract][Full Text] [Related]
16. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
[TBL] [Abstract][Full Text] [Related]
18. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
[TBL] [Abstract][Full Text] [Related]
19. Comparison of
Erber R; Stöhr R; Herlein S; Giedl C; Rieker RJ; Fuchs F; Ficker JH; Hartmann A; Veltrup E; Wirtz RM; Brueckl WM
Anticancer Res; 2017 Dec; 37(12):6771-6778. PubMed ID: 29187455
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.
Karakas D; Ozpolat B
J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
